Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 153 Lung Neoplasms 73 Pancreatic Neoplasms 44 Neoplasms 27 Neoplasm Metastasis 25 Head and Neck Neoplasms 23 Brain Neoplasms 21 Breast Neoplasms 18 Glioblastoma 15 Adenocarcinoma of Lung 15 Squamous Cell Carcinoma of Head and Neck 14 Gliosarcoma 14 Adenocarcinoma, Bronchiolo-Alveolar 11 Colorectal Neoplasms 10 Glioma 9 Carcinoma, Squamous Cell 8 Carcinoma, Hepatocellular 8 Adenocarcinoma 7 Rectal Neoplasms 6 Prostatic Neoplasms 6 Esophageal Neoplasms 6 Central Nervous System Neoplasms 6 Carcinoma, Renal Cell 6 Astrocytoma 6 Oligodendroglioma 5 Liver Neoplasms 5 Colonic Neoplasms 5 Carcinoma 5 Recurrence 4 Ovarian Neoplasms 4

Interventions

Gemcitabine 11 Albumin-Bound Paclitaxel 7 Taxes 5 130-nm albumin-bound paclitaxel 4 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Fluorouracil 3 dehydroftorafur 2 Oxaliplatin 2 Losartan 2 Leucovorin 2 Irinotecan 2 Cisplatin 2 niraparib 1 irinotecan sucrosofate 1 folfirinox 1 durvalumab 1 X-Rays 1 Surgical Procedures, Operative 1 Standard of Care 1 Specimen Handling 1 S 1 (combination) 1 Resistance Training 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Radiation 1 Panitumumab 1 Pancreaticoduodenectomy 1 Optical Imaging 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pancreatic Adenocarcinoma × Erlotinib Hydrochloride × Clear all

NCT01389440 2018-05-18

GEMCAD1003

Grupo Espanol Multidisciplinario del Cancer Digestivo

Phase 2 Completed

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡